English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Open

Kurokawa and other authors published 10-year outcomes of a Japanese randomized clinical trial comparing left thoracoabdominal approaches (LTA) with abdominal transhiatal approaches (TH) for adenocarcinoma of the esophagogastric junction (AEG) (JCOG9502) (1). That study demonstrated that LTA was not superior to TH regarding AEG patients’ survival, but had a higher incidence of morbidity than TH (2). Moreover, the authors stratified patients into Siewert type II or type III and showed that LTA should be avoided especially for the latter.

translational gastroenterology and hepatology

A commentary on “Ten-year follow-up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the oesophagogastric junction or gastric cardia”